Results of the AMI organized by the Foundation, SATT Toulouse and SATT AXLR

September 27, 2019 | News

Six projects have been selected Among them, several aim at developing new gene therapies. These include innovative strategies for the treatment of rare and severe neurological disorders, as well as a project aimed at developing new active molecules for the treatment of non-Hodgkin's T-cell lymphoma. Various files also concern the development of an original prognostic tool for antenatal medicine or an innovative therapeutic arsenal such as new molecules to treat small cell lung cancer.